CClinicalTrials.gg
CompletedNCT02334228Updated Jan 8, 2015

Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness

An interventional study of In SHAPE Lifestyles and Health Club Membership and Education in Schizophrenia, Bipolar Disorder and Schizoaffective Disorder, sponsored by Dartmouth-Hitchcock Medical Center. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2015-01-08.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
133
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Few studies targeting obesity in serious mental illness have reported clinically significant risk reduction, and non have been replicated in community settings or demonstrated sustained outcomes after intervention withdrawal. The researchers sought to replicate positive health outcomes demonstrated in a previous randomized effectiveness study of the In SHAPE program across urban community mental health organizations serving an ethnically diverse population.

Read the detailed description

In this randomized, controlled study, 133 adults age 21 and older with serious mental illness (SMI) and poor physical fitness (BMI>25, or \<10 minutes of exercise 2x over the past month) were randomized to either: a) In SHAPE Lifestyles (ISL) intervention or b) Health Club Membership and Education (HCME): consisting of a YMCA membership, educational materials on exercise and healthy diet, and an on-site introduction to the health club. The following three specific aims were addressed: 1) To compare ISL and HCME with respect to: a) participation in regular exercise and dietary change; (b) participation in preventive health care; and (c) improved fitness and health; (2) to compare ISL and HCME with respect to: (a) indicators of mental health and (b) personal self-efficacy; and (3) to explore differences in ISL and HCME with respect to (a) selected physical, metabolic, dietary, and community functioning secondary outcomes; and (b) the relationship of demographic variables and readiness to change to outcomes. ISL participants received a 6-month intensive program of one-to-one health mentoring, followed by a 3-month period of transitioning to self-directed individual and group programming, with assessments conducted at baseline, 3, 6, 9, and 12 months. If found to be effective, ISL will provide a practical approach to improving health, independent functioning, and longevity in disabled persons with SMI.

02

Conditions studied

  • Schizophrenia
  • Bipolar Disorder
  • Schizoaffective Disorder
  • Major Depressive Disorder
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 133 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 21 or older
  • Serious mental illness defined by an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia
  • Persistent impairment in multiple areas of functioning (e.g., work, school, self-care)
  • Body mass index (BMI) greater than 25
  • Able and willing to provide informed consent
  • On stable pharmacological treatment (same psychiatric medications over prior 2 months)

Exclusion criteria

Exclusion Criteria:

  • Residing in a nursing home of other institution
  • Diagnosis of dementia or significant cognitive impairment (MMSE\<24)
  • Unable to walk one city block
  • Pregnant or planning to become pregnant within the next 18 months
  • Unable to speak English
  • Terminal illness with life expectancy \<1 year
  • Current diagnosis of an active substance dependence disorder
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
133 participants (actual)

Study arms

  • Experimental
    In SHAPE Lifestyles

    In SHAPE Lifestyle is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.

    Behavioral: In SHAPE Lifestyles

  • Active comparator
    Health Club Membership and Education

    Fitness club membership with education in using the exercise equipment.

    Behavioral: Health Club Membership and Education

Interventions

  • BehavioralIn SHAPE Lifestyles

    In SHAPE Lifestyles is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.

  • BehavioralHealth Club Membership and Education

    Fitness club membership with education in using the exercise equipment.

06

What researchers measure

Primary outcomes

  1. Change in Exercise Capacity

    Change in fitness as measured by the 6-minute walk test.

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

Secondary outcomes

  1. Body Mass Index

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  2. Change in Weight

    Change in weight over time was measured at baseline, 3-, 6-, 9-, and 12-months. Measures were weight (lbs).

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  3. Change in Triglycerides and Cholesterol

    Change in triglycerides and cholesterol measured with the CardioChek PA Analyzer: Fasting blood glucose and lipids.

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  4. Change in Health Status

    Change in health status was measured by the SF-12: Medical Outcomes Study Short Form -12

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  5. Change in Community Functioning

    Change in community functioning was measured by the ILSS: Independent Living Skills Scale

    Time frame: Baseline, 9-, and 12-months

  6. Change in Physical Measurements (Fitness)

    Change is physical measurements was determined by measuring waist circumference and resting pulse

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  7. Change in Psychological State

    Change in psychological state was measured using the CESD: Cntr Epid Studies Dep; SANS: Scale Assess Neg Sx; R-SES: Revised Self-efficacy Scale

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  8. Change in Participation in Exercise

    Change in participation in exercise was determined by measuring weekly exercise at 3-, 6-, 9-, and 12-months using a physical activity log; weekly health club attendance at 3-, 6-, 9-, and 12-months based on frequency of YMCA visits; total physical activity at baseline, 3-, 6-, 9-, and 12-months based on the YPAS: Yale Physical Activity Scale.

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  9. Change in Diet Behaviors

    Change in diet behaviors was measured based on the WLB-SOC: Weight Loss Behavior State of Change Scale.

    Time frame: Baseline, 3-, 6-, 9-, and 12-months

  10. Change in Preventative Health Care

    Change in preventative health care was based on the PHC: Preventative Healthcare Checklist

    Time frame: Baseline and 12-months

07

Study locations

1 site
  • Riverbend Community Mental Health
    Concord, New Hampshire 03301, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02334228
Lead sponsor
Dartmouth-Hitchcock Medical Center
Responsible party
Sponsor
First posted
Jan 8, 2015
Start date
Sep 2006
Primary completion
Aug 2009
Completion
Aug 2009
Last update
Jan 8, 2015

Study contacts

Stephen J Bartels, MD,MS
principal investigator · Dartmouth-Hitchcock Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion